Published in Anticancer Res on May 01, 2013
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology (2011) 2.03
A developmental fMRI study of nonsymbolic numerical and spatial processing. Cortex (2007) 1.09
Local therapy of cancer with free IL-2. Cancer Immunol Immunother (2008) 0.93
Behavior of lipiodol markers during image guided radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys (2010) 0.89
In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels. J Control Release (2007) 0.88
Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study. Eur Urol (2003) 0.87
[Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin]. Medicina (Kaunas) (2009) 0.87
CoCanCPG. Coordination of cancer clinical practice in Europe. Tumori (2008) 0.86
"First do no harm" and the importance of prediction in oncology. EPMA J (2010) 0.86
In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy. Eur J Pharm Sci (2004) 0.86
Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis (2006) 0.85
Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res (2011) 0.84
Prediction of response in cancer immunotherapy. Anticancer Res (2011) 0.84
Subtoxic concentrations of allergenic haptens induce LC migration and maturation in a human organotypic skin explant culture model: a novel method for identifying potential contact allergens. Exp Dermatol (2006) 0.83
Immunophenotype and cytogenetics of mucinous tubular and spindle cell carcinoma of the kidney. Pol J Pathol (2007) 0.82
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update]. Pol Arch Med Wewn (2012) 0.81
Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy. Toxicol Ind Health (2006) 0.80
Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2. Cancer Immunol Immunother (2004) 0.79
Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer. World J Urol (2012) 0.78
A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample. BMC Cancer (2005) 0.78
[Bladder cancer biomarkers]. Przegl Lek (2010) 0.77
Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome? Rheumatol Int (2013) 0.77
Changes in cytokine profile during local IL-2 therapy in cancer patients. Anticancer Res (2006) 0.77
Does the "new philosophy" in predictive, preventive and personalised medicine require new ethics? EPMA J (2011) 0.77
A two-centre evaluation of the human organotypic skin explant culture model for screening contact allergens. Altern Lab Anim (2003) 0.76
Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer. Medicina (Kaunas) (2011) 0.76
Intratumoural interleukin-2 therapy can induce regression of non-resectable mastocytoma in dogs. Anticancer Res (2013) 0.76
The Amiens Strategy: small phase III trials for clinically relevant progress in the war against cancer. J Clin Oncol (2009) 0.76
Local interleukin-2 and interleukin-12 therapy of bovine ocular squamous cell carcinomas. Vet Immunol Immunopathol (2005) 0.75
Asynchronous collecting duct carcinoma of the kidney and pulmonary adenocarcinoma. A case report. Pol J Pathol (2002) 0.75
An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients. Medicina (Kaunas) (2011) 0.75
[Baloon dilatation of benign ureteroileal anastomotic strictures]. Przegl Lek (2010) 0.75
Three in one kidney. report of a case. Pol J Pathol (2004) 0.75
Expanded effector memory T-lymphocytes in DBA/2 mice do not inhibit the growth of SL2 tumours. In Vivo (2012) 0.75
Adrenal rest presenting as a renal cyst. A case report. Pol J Pathol (2003) 0.75
Combined studies of chemical composition of urine sediments and kidney stones by means of infrared microspectroscopy. J Biomed Opt (2013) 0.75
[Development of research at the Institute of Oncology of Vilnius University]. Medicina (Kaunas) (2004) 0.75